Evotec to acquire cell technology firm Rigenerand

Evotec has entered a definitive agreement for the acquisition of 100% of the capital of cell technology firm Rigenerand for $24.7m (€23m).

Related Keywords

Italy ,Reggio Emilia ,Emilia Romagna ,Medolla ,Evotec Evocells ,Werner Lanthaler ,University Of Modena ,Gene Therapy ,Pharmaceutical Technology ,Download Free Whitepaper ,Cytiva Thematic ,